Byrnes AP[au] - Search Results

Year	Number of Results
1992	1
1994	3
1995	1
1996	4
1997	2
1998	5
1999	1
2000	3
2004	3
2005	3
2006	3
2007	1
2008	4
2009	2
2010	1
2011	2
2013	2
2014	1
2015	1
2016	1
2017	1
2018	1
2019	1
2022	0

1

Interaction of adenovirus with antibodies, complement, and coagulation factors.

Allen RJ, Byrnes AP. Allen RJ, et al. Among authors: byrnes ap. FEBS Lett. 2019 Dec;593(24):3449-3460. doi: 10.1002/1873-3468.13649. Epub 2019 Nov 15. FEBS Lett. 2019. PMID: 31660588 Free article. Review.

2

Emergence and virulence of encephalitogenic arboviruses.

Griffin DE, Byrnes AP, Cook SH. Griffin DE, et al. Among authors: byrnes ap. Arch Virol Suppl. 2004;(18):21-33. doi: 10.1007/978-3-7091-0572-6_3. Arch Virol Suppl. 2004. PMID: 15119760 Review.

3

Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement.

Xu Z, Tian J, Smith JS, Byrnes AP. Xu Z, et al. Among authors: byrnes ap. J Virol. 2008 Dec;82(23):11705-13. doi: 10.1128/JVI.01320-08. Epub 2008 Sep 24. J Virol. 2008. PMID: 18815305 Free PMC article.

4

Evaluating the Impact of Natural IgM on Adenovirus Type 5 Gene Therapy Vectors.

Xu Z, Tian J, Harmon AW, Byrnes AP. Xu Z, et al. Among authors: byrnes ap. Methods Mol Biol. 2017;1643:187-196. doi: 10.1007/978-1-4939-7180-0_15. Methods Mol Biol. 2017. PMID: 28667539

5

Circulating antibodies and macrophages as modulators of adenovirus pharmacology.

Khare R, Hillestad ML, Xu Z, Byrnes AP, Barry MA. Khare R, et al. Among authors: byrnes ap. J Virol. 2013 Apr;87(7):3678-86. doi: 10.1128/JVI.01392-12. Epub 2013 Jan 16. J Virol. 2013. PMID: 23325678 Free PMC article.

6

Impact of natural IgM concentration on gene therapy with adenovirus type 5 vectors.

Qiu Q, Xu Z, Tian J, Moitra R, Gunti S, Notkins AL, Byrnes AP. Qiu Q, et al. Among authors: byrnes ap. J Virol. 2015 Mar;89(6):3412-6. doi: 10.1128/JVI.03217-14. Epub 2014 Dec 31. J Virol. 2015. PMID: 25552715 Free PMC article.

7

Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.

Harmon AW, Moitra R, Xu Z, Byrnes AP. Harmon AW, et al. Among authors: byrnes ap. PLoS One. 2018 Feb 5;13(2):e0192353. doi: 10.1371/journal.pone.0192353. eCollection 2018. PLoS One. 2018. PMID: 29401488 Free PMC article.

8

Heparin-binding and patterns of virulence for two recombinant strains of Sindbis virus.

Bear JS, Byrnes AP, Griffin DE. Bear JS, et al. Among authors: byrnes ap. Virology. 2006 Mar 30;347(1):183-90. doi: 10.1016/j.virol.2005.11.034. Epub 2005 Dec 27. Virology. 2006. PMID: 16380143 Free article.

9

Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.

Xu Z, Qiu Q, Tian J, Smith JS, Conenello GM, Morita T, Byrnes AP. Xu Z, et al. Among authors: byrnes ap. Nat Med. 2013 Apr;19(4):452-7. doi: 10.1038/nm.3107. Epub 2013 Mar 24. Nat Med. 2013. PMID: 23524342

10

Immune responses to adenovirus vectors in the nervous system.

Wood MJ, Charlton HM, Wood KJ, Kajiwara K, Byrnes AP. Wood MJ, et al. Among authors: byrnes ap. Trends Neurosci. 1996 Nov;19(11):497-501. doi: 10.1016/S0166-2236(96)10060-6. Trends Neurosci. 1996. PMID: 8931276 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results